Discover Great Companies
Discover Great Clients
Search
Leads Biolabs
+ Follow
Review
Feedback
Collect
Popularity
6030
|
Followers
4
|
Likes
2
Claim this company
Research and development of novel antibody drugs for tumors and other
No.260
Nanjing Popularity Ranking
No.38
Pukou District
Jiangsu
No.16
Yao Products R&D
No.17
Sheng Wu Ke Ji / Biotechnology Engineering
No.20
Lin Chuang Yi Xue
No.26
Pharmaceutical
No.31
Pharmaceutical Industrial
Ai Zheng Zhi Liao
Chuang Xin Liao Fa
市级创新型中小企业
独角兽企业
高新技术企业
省级高新技术企业
专精特新小巨人企业
+63%
Reviews
95
Salaries
Bachelor 46%
Requirements
5
Honors
生物/制 41%
R&D
4
News
1 rounds
Financing
20+
Competitors
37
Jobs
19
Master's
2
Partners
///
Bidding
Upstream/downstream partners, customers and suppliers
Follow companies
Copy company names
2条 Nanjing Leads Biolabs Co., Ltd. 上下游合作客户/供应商分析,包括战略合作/技术授权等。
Note: this data is AI-analysed and for reference only. By using this service you acknowledge this.
All
( 2 )
Suppliers
Customers
战略合作/技术授权
More
信达生物制药(苏州)有限公司
维立志博与信达生物共同开发PD-1/LAG-3双特异性抗体,信达生物获得中国大陆权益,维立志博保留海外权益。
Source
合作客户
战略合作/技术授权
+ Follow
百济神州(北京)生物科技有限公司
维立志博将LBL-007(LAG-3抗体)的全球开发与商业化权益授权给百济神州,百济神州支付首付款、里程碑付款及销售分成。
Source
合作客户
战略合作/技术授权
+ Follow
Discover Great Companies, Discover Great Clients
Nanjing
公司名录
Nanjing“Pukou District”
公司名录
Nanjing“医药”
公司名录
Nanjing“药物研发”
公司名录
Nanjing“生物科技/生物工程”
公司名录
Nanjing“临床医学”
公司名录
Nanjing“医药工业”
公司名录
附近的公司
We use cookies to enhance your browsing experience and analyze our traffic on Jobui. By continuing to use this site, you agree to our use of cookies.
Disagree
Agree